- Home
- XBIO vs NVFY Comparison
XBIO vs NVFY Comparison
Compare XBIO & NVFY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- XBIO
- NVFY
- Stock Information
- Founded
- XBIO N/A
- NVFY 2003
- Country
- XBIO United States
- NVFY United States
- Employees
- XBIO N/A
- NVFY N/A
- Industry
- XBIO Biotechnology: Pharmaceutical Preparations
- NVFY Home Furnishings
- Sector
- XBIO Health Care
- NVFY Consumer Discretionary
- Exchange
- XBIO Nasdaq
- NVFY Nasdaq
- Market Cap
- XBIO 5.8M
- NVFY 5.0M
- IPO Year
- XBIO N/A
- NVFY N/A
- Fundamental
- Price
- XBIO $2.79
- NVFY $1.07
- Analyst Decision
- XBIO Hold
- NVFY
- Analyst Count
- XBIO 1
- NVFY 0
- Target Price
- XBIO N/A
- NVFY N/A
- AVG Volume (30 Days)
- XBIO 10.2K
- NVFY 37.3K
- Earning Date
- XBIO 05-08-2025
- NVFY 05-14-2025
- Dividend Yield
- XBIO N/A
- NVFY N/A
- EPS Growth
- XBIO N/A
- NVFY N/A
- EPS
- XBIO N/A
- NVFY N/A
- Revenue
- XBIO $2,500,284.00
- NVFY $9,686,975.00
- Revenue This Year
- XBIO $14.23
- NVFY N/A
- Revenue Next Year
- XBIO N/A
- NVFY N/A
- P/E Ratio
- XBIO N/A
- NVFY N/A
- Revenue Growth
- XBIO N/A
- NVFY N/A
- 52 Week Low
- XBIO $2.20
- NVFY $0.39
- 52 Week High
- XBIO $5.20
- NVFY $2.83
- Technical
- Relative Strength Index (RSI)
- XBIO 51.08
- NVFY 78.49
- Support Level
- XBIO $2.32
- NVFY $0.62
- Resistance Level
- XBIO $2.61
- NVFY $0.91
- Average True Range (ATR)
- XBIO 0.16
- NVFY 0.10
- MACD
- XBIO 0.08
- NVFY 0.03
- Stochastic Oscillator
- XBIO 89.76
- NVFY 100.00
About XBIO Xenetic Biosciences Inc.
Xenetic Biosciences Inc is a biopharmaceutical company focused on advancing immune-oncology technologies addressing cancers. The company is also engaged in progressing XCART, a personalized CAR T platform technology. The Company's DNase platform is designed to improve outcomes of existing treatments, including immunotherapies, by targeting neutrophil extracellular traps (NETs), which have been implicated in cancer progression and resistance to cancer treatments. The company also has oncology therapeutic investigational drug candidate XBIO-101 for the treatment of progestin-resistant endometrial cancer.
About NVFY Nova Lifestyle Inc.
Nova Lifestyle Inc is a designer and lifestyle furniture company. It distributes and retails contemporary styled residential and commercial furniture. The firms marketing and sales platform offers retail as well as online selection and purchase fulfillment internationally. The company also sells managed a variety of bedding foundation components. Its collection of lifestyle furniture brands includes Diamond Sofa. The firm's products are made in the United States and Asia. Its customers mainly comprise distributors and retailers having specific geographic coverages that deploy middle to high-end private label home furnishings. The company operates in one business and industry segment: the design and sale of furniture.